Eucabal balm emulsion tube 40 ml

Instructions for Eucabal balm emulsion tube 40 ml

Composition

active ingredients: 100 g of emulsion contain: eucalyptus oil (Eucalypti aetheroleum) 10 g, pine oil (Pini sylvestris aetheroleum) 3 g;

excipients: cetostearyl alcohol, glycerol monostearate, macrogol stearate, sodium cetostearyl sulfate, trometamol, citric acid monohydrate, guaiazulene, purified water.

Dosage form

Emulsion.

Main physicochemical properties: Blue emulsion with the aroma of pine and eucalyptus oil.

Pharmacotherapeutic group

Antitussives in combination with expectorants.

ATX code R05F B02.

Pharmacological properties

Pharmacodynamics

The main active component of the drug is eucalyptus oil containing at least 80% of antispasmodically active 1,8-cineole. Its action is combined with the action of coniferous oil, which contains 30-40% alpha-pinenes, which improve blood supply. The pharmacological action of these essential oils leads to the dilution and dissolution of bronchial secretions, increased excretion by the ciliated epithelium, reduction of catarrhal manifestations in the respiratory tract, and anti-inflammatory action. Due to their lipophilic properties, the active substances are well distributed on the skin and absorbed. After absorption, they are partially excreted through the lungs, and therefore enter the bloodstream directly to the site of action. Thus, the preliminary effect that occurs during inhalation is enhanced by taking baths and, in the case of bed rest, is supplemented by the positive effect of a warm bath, which, in combination with the active substances, causes sweating.

Pharmacokinetics

Not studied.

Indication

To relieve symptoms of colds and respiratory diseases with excessive sputum production.

Contraindication

Hypersensitivity to any of the components of the drug. Bronchial asthma, whooping cough, pseudocroup, tendency to seizures. Damaged skin, for example, with burns and impaired skin integrity. Severe hypersensitivity of the respiratory tract, for example, with impaired vocal cord function.

Special safety precautions

Do not apply near the eyes, do not apply to mucous membranes. After applying the product, hands should be thoroughly dried to prevent contact with the face (especially the eyes). Care should be taken to ensure that children do not touch the treated skin with their hands. Cetylstearyl alcohol may cause local skin irritation (e.g. contact dermatitis).

Interaction with other medicinal products and other types of interactions

No interactions with other substances have been observed so far.

Use during pregnancy or breastfeeding

Since the safety of the drug during pregnancy has not been studied sufficiently, the balm should not be used during pregnancy. Do not apply to the breast area during breastfeeding.

The ability to influence the reaction speed when driving or working with other mechanisms

Does not affect.

Method of administration and doses

Evkabal® balm should be used for rubbing or inhalation.

Friction.

For rubbing, use Evkabal® balm undiluted.

Unless otherwise prescribed, apply a 2-3 cm strip of emulsion to the skin of the chest 2-3 times a day and rub in well (on a palm-width area). For children aged 6 months to 2 years, the drug can be applied only to the back. Care should be taken to prevent children from coming into contact with the applied emulsion (cover the area of the child's body with appropriate clothing).

Inhalation of vapors.

It is recommended to carry out 3 inhalations of steam daily for several days until the symptoms disappear. Dissolve a strip of emulsion 3-5 cm long (1 teaspoon) in 1-2 liters of hot water (not higher than 70 ° C) and inhale the steam under a towel placed on the head (the distance to the water should be at least 20 cm), or through an inhaler. When using an inhaler, mix the strip of emulsion with hot water in the lower part of the inhaler (for children aged 6 to 12 years - 2-3 cm, for children aged 12 years and adults - 3-5 cm).

If symptoms do not improve within 4-5 days or worsen, in case of shortness of breath, fever, or sputum with pus or blood, you should consult a doctor.

Children

For children aged 6 months to 2 years, the drug can be applied only to the back. In the form of inhalation, use from 6 years only under adult supervision.

Overdose

When used correctly in recommended doses, intoxication is practically excluded. In case of accidental internal intake of undiluted drug, gastrointestinal complications with nausea, vomiting, possible diarrhea, cramps should be expected. The resorptive effect should be considered only in extreme cases.

In mild cases, it is sufficient to discontinue the drug. In other cases, symptomatic treatment should be carried out. If convulsions occur, 5-10 mg of diazepam should be administered intravenously or a short-acting barbiturate, and in case of ingestion, the stomach should be washed and 30 g of sodium sulfate in 250 ml of water should be given.

Side effects

Allergic reactions, including skin rashes, itching, contact dermatitis, contact eczema, skin and mucous membrane irritation, bronchospasm.

Expiration date

For years.

Do not use the drug after the expiration date indicated on the package.

Storage conditions

Store out of the reach of children at a temperature not exceeding 25 °C.

Packaging

25 ml, or 40 ml, or 100 ml of emulsion in an aluminum tube in a cardboard box.

Vacation category

Without a prescription.

Producer

Esparma GmbH, Germany.

Address

Bielefelder Strasse 1, 39171 Sulzetal, Germany.

Applicant

Esparma GmbH, Germany.